Peter Ciszewski, CheckRare

Rare Disease Discussions

Health EN ↓ 192 episodes

News and clinical perspective including CME programs focused on rare diseases. CheckRare focuses on rare and neglected diseases.

Author

Peter Ciszewski, CheckRare

Category

Health

Podcast website

www.checkrare.com

Latest episode

Jul 1, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Cushing’s Syndrome Treatment Research Highlights: ENDO 2024Continuing Education 30.09.2024

This continuing education activity is provided by AffinityCE and CheckRare CE. This activity provides continuing education credit for physicians. A statement of participation is available for other attendees. Estimated time to complete: 0.50 hoursTo obtain CME credit, go to https://checkrare.com/learning/p-cushings-syndrome-treatment-research-highlights-endo-2024/ Commercial Support Educational Su...

CTCL: Shortening the Diagnostic Journey and Starting Treatment Early 30.09.2024

Yuliya Linhares, MD is a medical oncologist specializing in the comprehensive treatment of lymphoma and serves as chief of Lymphoma Services at Miami Cancer Institute. In this video, Dr. Linhares provides an overview of cutaneous T-cell lymphoma (CTCL) and discusses some strategies for shortening the diagnostic journey of this rare cancer. The diagnosis of CTCL is often challenging; as a result, d...

CTCL: The Role of Dermatologists in Diagnosing and Caring for Patients 26.07.2024

Larisa Geskin, MD, Professor of Dermatology at Columbia University Medical Center and Director of the Comprehensive Skin Cancer Center at the Division of Cutaneous Oncology in the Department of Dermatology, discusses the challenges of diagnosing cutaneous T-cell lymphoma (CTCL). The diagnosis of CTCL is often challenging; as a result, delays in diagnosis (and subsequently work-up and treatment) ca...

Myasthenia Gravis Research Highlights: AAN 2024 17.06.2024

Jointly Provided by American Academy of CME and CheckRare CE. Supported by educational grants from argenx US, Inc. and UCB Inc. To claim credit for this program, please visit https://checkrare.com/learning/p-myasthenia-gravis-research-highlights-aan-2024/ Estimated time to complete: 0.5 hours Start date: June 15, 2024 End date: June 30,2025 Activity Description This accredited CME program highligh...

Fabry Disease From a Patient’s Perspective, Featuring Maya Kineen 08.06.2024

In this episode of our series focused on Fabry disease, we feature Maya Kineen, a patient and advocate with this rare disorder. Fabry disease is an inherited disorder that results from the buildup of a particular type of fat, called globotriaosylceramide, in the body's cells. Beginning in childhood, this buildup causes signs and symptoms that affect many parts of the body. Characteristic features...

Signs and Symptoms of Fabry Disease, Featuring Nicola Longo, MD 08.06.2024

This is the second of a three-part series focusing on Fabry disease. In this episode, we talk with Nicola Longo, MD, Chief of the Division of Medical Genetics at the University of Utah, Spencer Fox Eccles School of Medicine in Salt Lake City. Dr. Longo discusses Fabry disease, including the progression of the disease and personalized medicine. Fabry disease is an inherited disorder that results fr...

Fabry Disease Overview, Featuring William Burns, MD 08.06.2024

In this first part of our four-part series on Fabry disease, we feature William Burns, MD, a biochemical geneticist at Greenwood Genetic Center in Greenwood, South Carolina. Dr. Burns summarizes this rare disease, including current management strategies. Fabry disease is a lysosomal storage disorder, meaning that a glycosphingolipid called GL-3 accumulates in the lysosomes, causing tissue damage;...

Kidney Involvement in Lysosomal Disorders 05.03.2024

Ozlem Goker-Alpan, MD, Founder and President, LDRTC and David G. Warnock, MD. Professor of Medicine (Emeritus) at University of Alabama at Birmingham discuss best practices to identify and treat kidney problems associated with lysosomal disorders. This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with kidney problems. This continuing educati...

HAE Treatment Advances: Highlights from ACAAI 03.03.2024

This 16-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the future treatment options for patients with hereditary angioedema (HAE) presented at ACAAI 2023. Jointly Provided by American Academy of CME and CheckRare CE. Support for this...

Hereditary Angioedema: Current Treatment Options 03.03.2024

This 25-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the current treatment options for patients with hereditary angioedema (HAE). Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing...

Assessing, Monitoring, and Managing Respiratory Involvement in Lysosomal Disorders 03.03.2024

Ozlem Goker-Alpan, MD of LDRTC and John Bach, MD, Professor of Neurology at Rutgers School of Medicine discuss best practices to manage respiratory complications in persons with lysosomal disorders. This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides...

Hereditary Angioedema: Current and Future Treatment Options 31.01.2024

This 40-minute CME-accredited program, hosted by Aleena Banerji, MD, Associate Professor at Harvard Medical School and Clinical Director of the Massachusetts General Hospital ( MGH) Allergy and Immunology Unit, highlights the current and future treatment options for patients with hereditary angioedema (HAE). Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited...

Alpha-Mannosidosis From a Mom’s Perspective, Featuring Rhonda Skipper 20.12.2023

In this final episode of our four-part series focused on alpha-mannosidosis, we feature Rhonda Skipper, a mom of two boys, Dale and Matt, who have this rare disease. Alpha-mannosidosis is a rare genetic disorder characterized by a deficiency of the enzyme alpha-D-mannosidase. Alpha-mannosidosis is best thought of as a continuum of disease that is generally broken down into three forms: a mild, slo...

Diagnosing and Managing Alpha-Mannosidosis, Featuring Markey McNutt, MD, PhD 20.12.2023

This is the third of a four-part series focusing on alpha-mannosidosis. In this episode, we feature Dr. Markey McNutt, who will focus on the challenges of identifying and caring for patients with this rare disease. Dr. McNutt is a Clinical Geneticist at the University of Texas Southwestern Medical Center in Dallas. Alpha-mannosidosis is a rare genetic disorder characterized by a deficiency of the...

Signs and Symptoms of Alpha-Mannosidosis, Featuring Reid Sutton, MD 20.12.2023

This is the second of a four-part series focusing on alpha-mannosidosis. In this episode, we talk with Dr. Reid Sutton on the challenges of recognizing this rare disease, focusing on the signs and symptoms. Dr. Sutton is a Clinical Geneticist and a Clinical Biochemical Geneticist at Baylor College of Medicine and Texas Children’s Hospital in Houston. Alpha-mannosidosis is a rare genetic disorder c...

Alpha-Mannosidosis Overview, Featuring Laura Buch, MSPAS, PA-C 20.12.2023

In this first part of our four-part series on alpha-mannosidosis, we feature Laura Buch, a physician assistant who practices medical genetics at the Greenwood Genetic Center in South Carolina. Laura’s work focuses on the diagnosis and treatment of patients with abnormal newborn screens, inborn errors of metabolism, and lysosomal storage disorders. She also cares for alpha-mannosidosis patients. Al...

Myasthenia Gravis and the Complement System: Treatment Options 19.12.2023

This 30-minute CME-accredited program highlights the connection between the complement system and myasthenia gravis in regards to the treatment of this rare disease. Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing education activity has been made possible through educational grant from UCB. Start date: December 18, 2023. End date: December 18, 2...

Myasthenia Gravis and the Complement System: Pathophysiology 19.12.2023

This 15-minute CME-accredited program highlights the connection between the complement system and myasthenia gravis in regards to the pathophysiology of this rare disease. Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing education activity has been made possible through educational grant from UCB. Start date: December 18, 2023. End date: December...

Myasthenia Gravis and the Complement System 19.12.2023

This 45-minute CME-accredited program highlights the connection between the complement system and myasthenia gravis in regards to the pathophysiology and treatment of this rare disease. Jointly Provided by American Academy of CME and CheckRare CE. Support for this accredited continuing education activity has been made possible through educational grant from UCB. Start date: December 18, 2023. End...

New Guidance To Treat Tumor-induced Osteomalacia (TIO) 01.12.2023

Jointly Provided by American Academy of CME and CheckRare CE Support for this accredited continuing education activity has been made possible through an educational grant from Kyowa Kirin. Estimated time to complete: 0.25 hours Start date: November 30, 2023 End date: November 30, 2024 This 15-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster Univer...

New Guidance To Diagnose Tumor-induced Osteomalacia (TIO) 01.12.2023

Jointly Provided by American Academy of CME and CheckRare CE Support for this accredited continuing education activity has been made possible through educational grant from Kyowa Kirin. Estimated time to complete: 0.25 hours Start date: November 30, 2023 End date: November 30, 2024 This 15-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster Universit...

New Guidance To Diagnose and Treat Tumor-induced Osteomalacia (TIO) 01.12.2023

Jointly Provided by the American Academy of CME and CheckRare CE Support for this accredited continuing education activity has been made possible through an educational grant from Kyowa Kirin. Estimated time to complete: 0.50 hours Start date: November 30, 2023 End date: November 30, 2024 This 15-minute CME-accredited program, hosted by Aliya Khan, MD, Clinical Professor of Medicine at McMaster Un...

Cushing's Disease Research Highlights: ENDO 2023 16.10.2023

This 30-min CME program provides an overview of the latest clinical research presented at ENDO 2023 involving Cushing’s disease. Faculty Lisa Nachtigall, MD Clinical Director, Neuroendocrine & Pituitary Tumor Clinical Center Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Learning Objectives - After participating in the activity, learners should be better...

CME: Managing Cardiomyopathies in Lysosomal Disorders 05.10.2023

This CME/CE activity describes the pathophysiologies and management options for lysosomal disease patients with cardiomyopathies. This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nu...

Acromegaly Research Highlights: ENDO 2023 05.10.2023

This 30-minute CME program highlights the latest clinical research about acromegaly, a rare, endocrine disorder. Activity Faculty Wenyu Huang, MD, PhD Associate Professor Northwestern University Feinberg School of Medicine Chicago, IL Support for this accredited continuing education activity has been made possible through educational grants from Recordati Rare Diseases Inc. and Ipsen Biopharmaceut...

Listen to the Rare Disease Discussions podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.